-- Sunstone Metals(ASX:STM)周二向澳大利亚证券交易所提交的文件显示,其位于厄瓜多尔的Bramaderos金铜项目的初步可行性研究显示,该项目初始矿山寿命为23年,前8年每年可生产13.5万盎司黄金当量。 该公司表示,该研究得出,在金价为每盎司3500美元的情况下,税后净现值为9亿美元,扣除各项抵免后,维持成本(AISC)平均为每盎司1499美元。 Sunstone Metals表示,该项目为传统的单露天矿,矿石将供应给一座年处理能力为1000万吨的选矿厂,矿山剥采比为1.4。在金价为每盎司3500美元的情况下,预计资本回收期为34个月;在现货价格下,预计资本回收期为19个月。 该公司表示,库存的显著增长潜力可能支撑二期扩建计划。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.